Ricoh joins fight against Alzheimer’s disease
New partnership with leading global charity, Alzheimer’s Research, on World Alzheimer's Day
Ricoh Europe, London, 21 September 2017 – Ricoh is tackling dementia through a pan-European partnership with Alzheimer’s Research, Europe’s leading dementia research charity.
The partnership will see Ricoh and Alzheimer’s Research co-produce a number of awareness campaigns, leveraging Ricoh’s printing technologies and digital capabilities.
Ricoh will also take part in generating much-needed research funding through a series of volunteering activities. The funds raised will support world-class researchers as they work to grow the body of science behind the complex diseases that cause dementia, most commonly Alzheimer’s disease.
Participating Ricoh companies in Europe will also host a range of employee engagement and fundraising activities. The sessions will educate staff on the symptoms, causes and impact of dementia, as well as the current progress of research.
Javier Diez-Aguirre, Vice President, Corporate Marketing, CSR & Environment, Ricoh Europe, says, “Ricoh shares the mission of Alzheimer’s Research to help bring about the first life-changing dementia treatment by 2025. We are now committing our people, technologies and expertise to contribute to achieving this mission. We are proud of our partnership with Alzheimer’s Research. We can’t wait to put our collective thinking, energy and passion into practice to help defeat dementia.”
Timothy Parry, Director of Communications and Partnerships at Alzheimer’s Research, says, “We are proud to unveil our partnership with Ricoh Europe on World Alzheimer’s Day. This is a hugely influential company that leads its field in technical innovation, and through the partnership, Ricoh Europe is demonstrating that corporations of all types can play a meaningful role in overcoming our great medical challenge. We are grateful for the support of Ricoh Europe’s leadership and staff, and through our collaboration we are determined to help enable research breakthroughs that bring hope to individuals and families affected by dementia around the world”.